活络利水饮治疗钙离子拮抗剂导致下肢水肿(瘀水互结型)临床观察
[Abstract]:Objective: to evaluate the clinical efficacy and TCM syndrome score of Huoluo Lishuiyin in the treatment of lower extremity edema caused by water stasis type calcium antagonists, and to explore its mechanism. Methods: from June 2014 to March 2015, 60 patients with mild to moderate essential hypertension with edema after taking amlodipine (22 cases) and nifedipine (38 cases) were included in the study. Sixty patients were randomly divided into treatment group (n = 30) and control group (n = 30). The treatment group was treated with Huoluo Lishui decoction on the basis of the standard hypotension of western medicine, and the control group was treated with a certain dose of diuretics for 6 weeks. The degree of edema, the changes of TCM syndrome score and other adverse events were observed and compared before and after treatment, and the data were statistically analyzed by SPSS19.0 software. Results: 1. Compared with the control group, there were 13 cases of edema, 15 cases of mild edema, 2 cases of still edema of foot, 4 cases of no edema, 6 cases of mild edema and 20 cases of still edema of foot in the treatment group and the control group after treatment with traditional Chinese medicine (TCM) treatment group (13 cases), 15 cases (15 cases), 2 cases (2 cases), 4 cases (4 cases), 6 cases (6 cases) and 20 cases (20 cases). After chi-square test, the treatment group had obvious advantages over the control group (P01). 2. The degree of foot back depression was 2.67 卤0.52 mm before treatment, 0.55 卤0.44 mm after treatment and 0.78 卤0.16 before treatment, and 2.58 卤0.55 mm before treatment, 1.51 卤0.76 mm after treatment and 0.43 卤0.25 mm after treatment in the control group, and there was significant difference between the two groups before and after treatment (P 0.01, P < 0.05), and the degree of foot back depression was 2.67 卤0.52 mm before and after treatment, 0.55 卤0.44 mm and 0.78 卤0.16 before and after treatment, and 2.58 卤0.55 mm before treatment, 1.51 卤0.76 mm after treatment and 0.43 卤0.25 mm after treatment. In the treatment group, 35.59 卤4.24 cm after leg eluting, 37.90 卤4.12 cm before treatment and 35.77 卤4.25 cm after treatment, the treatment range was 0.92 卤0.42, while that in the control group was 36.22 卤4.80 cm, 38.5 卤4.70 cm before and 37.53 卤4.64 cm after treatment, and the treatment range was 0.43 卤0.08 before and after treatment. In the treatment group, 25.53 卤3.55 cm after neck circumference eluting, 28.08 卤3.60 cm before treatment, 25.77 卤3.55 cm after treatment, and 0.90 卤0.03 cm after treatment. In the control group, 25.88 卤4.53 cm after foot neck eluting, 28.23 卤4.41 cm before treatment and 26.85 卤4.54 cm after treatment, the range of treatment was 0.41 卤0.07. There was significant difference between the two groups before and after treatment by t test (P 0.01). The treatment range of the two groups was significantly different by group t test, and the treatment group was significantly better than the control group. 5. After treatment, the total score of TCM syndromes in the treatment group and the control group was significantly lower than that in the control group (P 0.01), but the total score in the treatment group was significantly lower than that in the control group (P 0.01). The total effective rate of TCM syndrome in the treatment group was 100%, which was significantly higher than that in the control group (40.00%) (P 0.01). The total effective rate of each symptom in the treatment group was better than that in the control group, and the improvement of each symptom was significantly better than that in the control group (P 0.01). Conclusion: the treatment group is superior to the control group in improving the antiswelling effect and clinical symptoms of lower extremity edema caused by calcium antagonists.
【学位授予单位】:山东中医药大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R544.1
【相似文献】
相关期刊论文 前10条
1 阎亚非;;用钙离子拮抗剂治疗雷诺氏现象[J];心血管病译文;1986年02期
2 耿东进;;钙离子拮抗剂治疗中风的研究[J];中风与神经疾病杂志;1993年01期
3 孙宁玲;钙离子拮抗剂与动脉粥样硬化的干预[J];继续医学教育;2005年09期
4 陈慧英;张平华;;钙离子拮抗剂的合理应用[J];首都医药;2006年16期
5 张劲松;王健;;长效钙离子拮抗剂的研究进展[J];中国误诊学杂志;2007年03期
6 周辉;余红;韩淑英;;钙离子拮抗剂临床应用研究进展[J];华北煤炭医学院学报;2009年02期
7 杨运清;;钙离子拮抗剂治疗早产的临床观察[J];中外医学研究;2011年27期
8 陈大年;钙离子拮抗剂保护心脏的新概念:缺血选择性[J];心血管病学进展;1995年04期
9 邓雪蔚,李晋,孙克春;成都市血管紧张素转换酶抑制剂和钙离子拮抗剂市场分析[J];中国新药杂志;1999年06期
10 陈海翎,华琦,杨峥;钙离子拮抗剂用于降血压治疗的新进展[J];中国医药导刊;2002年04期
相关会议论文 前2条
1 朱慕云;许文景;丁平;李梅;葛辉;;钙离子拮抗剂治疗慢阻肺所致肺动脉高压的临床研究[A];中华医学会血液学分会第十三届全国血栓与止血学术会议暨“血栓栓塞性疾病(血栓与止血)基础与临床研究进展”论文摘要汇编及学习班讲义[C];2011年
2 刘国树;;钙离子拮抗剂在心血管疾病的应用[A];2005年中国高血压年会论文汇编[C];2005年
相关重要报纸文章 前10条
1 浙江省温州市中医院 赵燕云邋董飞侠;钙剂与钙离子拮抗剂不矛盾[N];健康报;2007年
2 赵燕云;同时使用钙剂与钙离子拮抗剂不矛盾[N];家庭医生报;2007年
3 赵燕云 董文;钙剂与钙离子拮抗剂可合用[N];医药经济报;2009年
4 汪涛;绝经妇女服钙离子拮抗剂增加乳癌风险[N];大众卫生报;2005年
5 张依秋;绝经妇女慎服钙离子拮抗剂[N];保健时报;2003年
6 佳;钙离子拮抗剂作为一线抗高血压药物有争议[N];中国高新技术产业导报;2001年
7 董飞侠;穿越补钙的“迷雾”[N];医药经济报;2007年
8 王超;糖尿病伴高血压怎样选药[N];医药养生保健报;2008年
9 江西 副研究员 杨宁;钙离子拮抗剂与地高辛不宜合用[N];家庭医生报;2005年
10 龙安民;选降压药应因人而异[N];大众卫生报;2002年
相关硕士学位论文 前4条
1 付莛凯;钙离子拮抗剂围手术期应用对面肌痉挛术后并发症的疗效观察[D];济南大学;2012年
2 赵郁虹;不同钙离子拮抗剂对肾小球系膜细胞增殖的影响[D];中国医科大学;2005年
3 殷磊;活络利水饮治疗钙离子拮抗剂导致下肢水肿(瘀水互结型)临床观察[D];山东中医药大学;2015年
4 袁野;高血压病不同证候人群中西药临床治疗数据挖掘研究[D];南京中医药大学;2013年
,本文编号:2505760
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2505760.html